Literature DB >> 23482802

Prostate cancer detection at repeat biopsy: can pelvic phased-array multiparametric MRI replace saturation biopsy?

Pietro Pepe1, Antonio Garufi, Giandomenico Priolo, Giuseppe Candiano, Francesco Pietropaolo, Michele Pennisi, Filippo Fraggetta, Francesco Aragona.   

Abstract

AIM: Magnetic resonance imaging (MRI) accuracy in prostate cancer (PCa) diagnosis in men submitted to saturation prostate biopsy (SPBx) was evaluated.
MATERIALS AND METHODS: From June 2011 to December 2012, 78 patients (median 63 years) underwent repeat SPBx (median 28 cores). Multiparametric MRI using a 3 Tesla pelvic phased-array coil was performed before SPBx and lesions suspicious for PCa were submitted to additional targeted biopsies.
RESULTS: A T1c PCa was found in 32 (41%) cases. SPBx vs. MRI-suspicious targeted biopsy diagnosed 28 (87.5%) vs. 26 (81.2%) PCa missing four (12.5%) and six (18.8%) cancers localized in the anterior zone and in the lateral margin of the prostate, respectively; moreover, MRI diameter lesions correlated with PCa diagnosis and Gleason score (p<0.05).
CONCLUSION: Multiparametric MRI improved SPBx accuracy in diagnosing PCa of the anterior zone; moreover, suspicious areas >10 mm resulted as highly predictive of cancer (about 70% of the cases).

Entities:  

Mesh:

Year:  2013        PMID: 23482802

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  14 in total

Review 1.  Comparison of image-guided targeted biopsies versus systematic randomized biopsies in the detection of prostate cancer: a systematic literature review of well-designed studies.

Authors:  Antoine van Hove; Pierre-Henri Savoie; Charlotte Maurin; Serge Brunelle; Gwenaëlle Gravis; Naji Salem; Jochen Walz
Journal:  World J Urol       Date:  2014-06-12       Impact factor: 4.226

2.  Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer.

Authors:  Frank-Jan H Drost; Daniël F Osses; Daan Nieboer; Ewout W Steyerberg; Chris H Bangma; Monique J Roobol; Ivo G Schoots
Journal:  Cochrane Database Syst Rev       Date:  2019-04-25

3.  Can MRI/TRUS fusion targeted biopsy replace saturation prostate biopsy in the re-evaluation of men in active surveillance?

Authors:  Pietro Pepe; Antonio Garufi; Giandomenico Priolo; Michele Pennisi
Journal:  World J Urol       Date:  2015-12-23       Impact factor: 4.226

4.  [Prostate cancer detection rates: comparison of standard biopsy with prompt rebiopsy and a one-time extended biopsy].

Authors:  Z Türk; H Hollberg; T Dill; I Kaspers; H Isbarn
Journal:  Urologe A       Date:  2015-01       Impact factor: 0.639

5.  Prostate biopsy: results and advantages of the transperineal approach--twenty-year experience of a single center.

Authors:  Pietro Pepe; Francesco Aragona
Journal:  World J Urol       Date:  2013-06-07       Impact factor: 4.226

6.  Evidence-based guideline recommendations on multiparametric magnetic resonance imaging in the diagnosis of prostate cancer: A Cancer Care Ontario clinical practice guideline.

Authors:  Masoom A Haider; Xiaomei Yao; Andrew Loblaw; Antonio Finelli
Journal:  Can Urol Assoc J       Date:  2017-01-12       Impact factor: 1.862

7.  Multiparametric MRI Apparent Diffusion Coefficient (ADC) Accuracy in Diagnosing Clinically Significant Prostate Cancer.

Authors:  Pietro Pepe; Davide D'Urso; Antonio Garufi; Giandomenico Priolo; Michele Pennisi; Giorgio Russo; Maria Gabriella Sabini; Lucia Maria Valastro; Antonio Galia; Filippo Fraggetta
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

8.  Erectile dysfunction in 1050 men following extended (18 cores) vs saturation (28 cores) vs saturation plus MRI-targeted prostate biopsy (32 cores).

Authors:  P Pepe; M Pennisi
Journal:  Int J Impot Res       Date:  2015-08-20       Impact factor: 2.896

9.  Clinicopathologic characteristics of anterior prostate cancer (APC), including correlation with previous biopsy pathology.

Authors:  Martin J Magers; Tianyu Zhan; Aaron M Udager; John T Wei; Scott A Tomlins; Angela J Wu; Lakshmi P Kunju; Madelyn Lew; Felix Y Feng; Daniel A Hamstra; Javed Siddiqui; Arul M Chinnaiyan; Jeffrey S Montgomery; Alon Z Weizer; Todd M Morgan; Brent K Hollenbeck; David C Miller; Ganesh S Palapattu; Hui Jiang; Rohit Mehra
Journal:  Med Oncol       Date:  2015-10-06       Impact factor: 3.064

10.  Multiparametric MRI Versus SelectMDx Accuracy in the Diagnosis of Clinically Significant PCa in Men Enrolled in Active Surveillance.

Authors:  Pietro Pepe; Giuseppe Dibenedetto; Ludovica Pepe; Michele Pennisi
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.